𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis

✍ Scribed by Lorenz Leitritz; Matthias Griese; Andreas Roggenkamp; Anna Maria Geiger; Volker Fingerle; Jürgen Heesemann

Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
206 KB
Volume
193
Category
Article
ISSN
0300-8584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic differences in cystic fibrosis p
Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency
✍ Maurizio Ferrari; Mariano Antonelli; Fiorenza Bellini; Graziella Borgo; Ornella 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 447 KB

To determine the number and frequency of mutations that occur at the cystic fibrosis locus (CF), we have examined the allele and haplotype frequencies of eight polymorphic DNA markers linked to CF in 163 Italian patients who were sub-divided according to their clinical presentations. The distributio

Epidemiologic study of cystic fibrosis:
Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
✍ Wayne J. Morgan; Steven M. Butler; Charles A. Johnson; Andrew A. Colin; Stacey C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 2 views

## for the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis Summary. Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk fact

Liver disease in cystic fibrosis: A pros
Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome
✍ Carla Colombo; Pier Maria Battezzati; Andrea Crosignani; Alberto Morabito; Diana 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

Incidence of liver disease (LD) associated with cystic fibrosis (CF) and its clinical characterization still is unsettled. We have assessed prospectively the incidence and risk factors of this complication, and its impact on the clinical course of CF. Between 1980 and 1990, we enrolled 177 CF patien

Abnormal fatty acid pattern of the plasm
Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency
✍ V. Rogiers; A. Vercruysse; I. Dab; D. Baran 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 399 KB

In our previous work it was found that in cystic fibrosis patients with and without pancreatic insufficiency, the fatty acid pattern of the plasma long chain, non-esterified fatty acid fraction is strikingly abnormal in comparison with the corresponding pattern of healthy subjects. However, other in

Multicenter, open-label study of recombi
Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease
✍ H. Karsten Harms; Elias Matouk; Guy Tournier; Horst von der Hardt; Peter H. Well 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Cystic fibrosis is characterized by the accumulation of thick viscous purulent secretions. Recombinant human deoxyribonuclease I (rhDNase) breaks down extracellular DNA, which contributes to the increased viscosity of sputum. A multinational, open-label study was conducted in 974 cystic fibrosis pat